Skip to content

Clinical trials

Lung Diseases trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Switzerland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20101
20131
20141
20164
20171
20181
20192
20204
20211
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Terminated3
Unknown status3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Zurich4
Insel Gruppe AG, University Hospital Bern3
Eli Lilly and Company2
Apeiron Biologics1
AstraZeneca1
Bayer1
Blueprint Medicines Corporation1
Centre Hospitalier Universitaire Vaudois1
Drahomir Aujesky1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases24
Respiratory Tract Diseases8
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms7
Neoplasms6
Carcinoma, Bronchogenic4
Cardiovascular Diseases4
Neoplasms by Site4
Respiratory Tract Neoplasms4
Thoracic Neoplasms4

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.